Autism spectrum disorders (ASDs) are complex neurodevelopmental disorders characterized by a combination of deficits in communication and social interaction and repetitive, stereotyped behavior and interests. 1 Recent research has focused on the possible association between maternal autoimmunity and the development of ASDs. 2 Antibodies specific for fetal brain proteins have been found in the plasma of mothers to children with ASDs. [3] [4] [5] However, maternal sensitization does not seem to fully explain the development of ASDs, because mothers with unaffected children can have a similar antibody profile. Hence, a complex relationship between maternal antifetal brain antibodies, in utero environmental factors, and genetics is likely to predispose to the development of ASDs. 6, 7 A number of epidemiologic studies have investigated the association between ASDs and family history of autoimmune diseases (ADs). Croen et al 8 found an increased risk of ASDs in the child if the mother was diagnosed with psoriasis. Comi et al 9 found a statistically significant association between ASDs and family history of all ADs combined, as well as a family history of rheumatoid arthritis (RA), specifically. Sweeten et al 10 found a higher frequency of overall autoimmunity and, specifically, thyroid gland AD in families of children with pervasive developmental disorder. Mouridsen et al 11 performed a cross-sectional, case-control study on Danish register data using case records of 111 individuals diagnosed with infantile autism between 1960 and 1984. They found an association between maternal diagnosis of ulcerative colitis and paternal diagnosis of type 1 diabetes (T1D) and infantile autism. Micali et al 12 found no increased prevalence of any AD among parents of children with pervasive developmental disorder compared with normally developed children. In each of the studies, numerous ADs were investigated independently for an association with ASDs/infantile autism.
The previous studies have several limitations, such as relatively small study samples, [8] [9] [10] [11] [12] the use of self-response questionnaires, 10 recall bias, 9 a possible misclassification of autism cases, 8 and exposure status. 12 The present study uses nationwide registers based on standardized diagnostic procedures to find case subjects with ASDs and family members diagnosed with AD. We included only diagnoses reported by medical doctors, and by using registers we avoided recall bias and reliance on self-response questionnaires. Furthermore, the study sample in this study is Ն10 times larger than study samples used in previous studies. The aim of this study was to confirm the above-mentioned associations found in previous studies, as well as to explore the relationship between family history of other ADs and ASDs/infantile autism. For all of the ADs, we differentiated between maternal history of AD (representing possible exposures in the fetal environment or prenatal antibody exposure, as well as a potential genetic exposure) and paternal history of AD (representing only potential genetic exposure).
METHODS

Study Population
We used data from the Danish Civil Registration System 13 to identify all of the children born in Denmark from January 1, 1993, through December 31, 2004 , who survived the first year of life and whose mother was born in Denmark (689 196 children). All live-born children and new residents in Denmark are assigned a unique personal identification number (Central Person Register [CPR] number), which is stored in the Danish Civil Registration System. The CPR number is used as a key to individual information in all of the national registers, ensuring accurate linkage of information between registers.
Diagnostic System
The Danish modification of the International Classification of Diseases, Eighth Revision (ICD-8), was introduced as a diagnostic instrument in Denmark in 1969 and used until 1993. In 1994, ICD-8 was replaced by the 10th revision (ICD-10). Health care service in Denmark is free of charge and easily accessible for the whole population.
Autism in Cohort Members
The study population was linked with the Danish Psychiatric Central Register (DPCR). 14 The DPCR includes information on all inpatient admissions to psychiatric hospitals and psychiatric wards in general hospitals in Denmark since 1969 and all outpatient contact since 1995. The DPCR includes the CPR number, diagnosis, dates of admission and discharge, and terms of admission. All of the diagnoses registered in the DPCR are made by psychiatrists.
Cohort members were classified with ASDs if they had been admitted or been in outpatient care with a diagnosis in the autism spectrum (ICD-10 diagnostic codes as follows: infantile autism, F84.0; atypical autism, F84.1; Asperger syndrome, F84.5; and pervasive developmental disorder, not otherwise specified, F84.8 and F84.9). The study population was followed from age 1 year until date of first diagnosis of ASDs (or infantile autism), death, emigration from Denmark, or December 31, 2006.
ADs in Parents and Siblings
Information on AD in parents and siblings of the cohort members was obtained from the Danish National Hospital Register (DNHR). 15 The DNHR was initiated in 1977 and includes detailed information on all hospital admissions in the entire country. The recorded information includes the CPR number, diagnosis, hospital, and dates of admission and discharge. Inpatient visits have been included since 1977, whereas outpatient and emergency department visits have been included since 1995. Parents and siblings were classified with a history of AD if they had been admitted or been in outpatient care with 1 of the 26 AD diagnoses included in the study (Table 1) .
Analytic Approach
The incidence rate ratio (IRR) of ASDs was estimated by log-linear Poisson regression 16 with the GENMOD procedure in SAS 9.1 (SAS Institute, Inc, Cary, NC). Calendar year, age at diagnosis for ASDs, and its interaction with gender, place of birth, and age of the mother and father at the time of the child's birth were regarded as possible confounders, and all of the IRRs were adjusted for these variables. We included information of AD in the family as a time-dependent covariate, because otherwise exposure status and results would depend on the total length of follow-up time included the study. Including AD in the family as a time-dependent covariate implies that only ADs diagnosed before the date of diagnosis of ASDs in the child are included in the analysis. Age and calendar year were also treated as timedependent variables, 17 whereas all of the other variables were treated as independent of time. Calendar year was categorized in 1994 -1996 in the earliest period and then in 1-year periods afterward. Age was categorized in 6-month periods from 1 to 3 years of age, and thereafter 1-year periods were used. Maternal age at the time of the child's birth was categorized with cutoff points at 12, 20, 25, 30, 35, and 40 years, and paternal age had cutoff points of 12, 25, 30, 35, 40, and 45 years or unknown father. The difference in age categorization for mothers and fathers is to avoid age groups with very few observations (there are more mothers in the younger categories and more fathers in the older categories). P values and 95% confidence limits were based on likelihood ratio tests. 17 The adjustedscore test 18 suggested that the regression models were not subject to overdispersion. No adjustment was made for multiple testing.
Primary analyses involve investigating significant findings from previous studies, that is, the relationship between ASDs or infantile autism and (1) family history of all ADs combined, (2) family history of RA, (3) maternal psoriasis, (4) paternal T1D, (5) maternal ulcerative colitis, and (6) family history of AD in the thyroid gland. Analyses on the association between other ADs and ASDs/infantile autism are regarded as exploratory and, thus, secondary. For all ADs, we estimated the IRR of ASDs/ infantile autism after the mother, father, or sibling was diagnosed with AD (reference group: children with no family history of AD); using exclusively the maternal history of AD (reference group: children with no parental history of AD); or using exclusively the paternal history of AD (reference group: children with no parental history of AD). An IRR estimate was not calculated if fewer than 5 case subjects were exposed.
We performed a stratified analysis including children with a gestational age of Ն37 weeks, a birth weight of Ͼ2500 g, and a 5-minute Apgar score of Ͼ6. This analysis was performed in an attempt to 
RESULTS
Primary Analyses
A total of 3325 children were diagnosed with ASDs, of which 1089 had an infantile autism diagnosis (Table 2) . No statistically significant association was found between all of the ADs combined and ASDs (Table 3 ) or infantile autism (Table  4) . Endocrine AD in the father was found to be associated with a higher IRR of infantile autism, probably caused by the significant association between T1D and infantile autism (family history of T1D 
DISCUSSION
The study confirms previous findings of an increased risk of ASDs for children with a family history of RA. 9 We add to previous knowledge by suggesting that this increased risk is possibly limited to maternal history of RA. This suggests that the association between RA and ASDs is caused by a prenatal exposure to maternal antibodies or fetal environment during gestation. It is well known that autoantibodies can transfer from the mother to the fetus in women affected by certain ADs in connective tissue. 20 However, it is known that pregnancy exerts a beneficial effect on the symptoms and signs of RA: ϳ75% of patients experience improvement or even remission of arthritis during gestation, 21 and studies of pregnant patients with RA have shown a cytokine expression similar to that found in healthy pregnant women. 22 Also, the recommended treatment of disease flare-ups during pregnancy is considered safe for the fetus and child during the period of breastfeeding. 23 Warren et al 24 found that the third hypervariable region on the HLA-DR B1 gene is associated with both RA and infantile autism, implying that RA and infantile autism may have some common genetic background. Other immune-based genes found associated with ASDs include HLA-DR4, 25, 26 HLA-DR13, 25 and HLA-A2. 27 Another previous finding was confirmed concerning increased risk of infantile autism for children with a paternal history of T1D. 11 We found, however, an association between both paternal and maternal history of T1D, suggesting a common genetic factor. Limited research has been done on a possible common genetic profile of infantile autism and T1D, but an increased frequency of complement C4B null allele has been found in both diseases. 28, 29 Several studies have suggested a greater prevalence of ASDs in children with diabetes compared with the general population. 30, 31 The observed increased risk of ASDs after a history of maternal T1D could possibly be caused by comorbidities with the mother's condition. For example, a state of hypoglycemia or long-standing hyperglycemia in the fetus of a diabetic mother has serious effects for the developing brain. 32 However, this would not explain the increased risk associated with paternal T1D.
Maternal diagnosis of celiac disease was found to be associated with ASDs. Previous studies have found associations between undiagnosed celiac disease in pregnancy and intrauterine growth reduction of the fetus, 33,34 low birth weight, 33, 34 and early gestational age, 34 which also are risk factors for ASDs. 35 However, celiac disease diagnosed before pregnancy does not seem to constitute a risk of adverse fetal outcome, indicating the importance of treatment of pregnant women with celiac disease. 33, 34 Previous studies have suggested an association between celiac disease and psychiatric diseases. Eaton et al 36 found an increased risk of schizophrenia for individuals with a parental history of celiac disease. Previous studies investigating celiac disease in the child itself and autism have not found a significant association. 37, 38 The present study is the first to investigate the association between family history of celiac disease and autism, and this finding needs replication in other study populations. 39 No statistically significant association was found between psoriasis and ASDs, as suggested by Croen et al. 8 This could be explained by the use of data on hospital contact (excluding primary care) in the present study as opposed to data on all medical contacts (including primary care) in the study by Croen et al. 8 In the present study, limited completeness of exposure data possible resulted in a weaker observed association between familial AD and ASDs. The significantly lower risk of ASDs after family history of thyrotoxicosis is contradictory to results from most other studies [9] [10] [11] ; however, Croen et al 8 found an odds ratio of 0.6 (95% CI: 0.3-1.2) of ASDs after including maternal autoimmune thyroid diseases.
We had no data on potential exacerbation of AD activity during pregnancy or the probable use of medication during pregnancy. Previous studies have suggested that women with AD have an increased risk of developing certain obstetric complications, such as preterm birth, fetal growth restriction, or asphyxia, 32, 40, 41 factors that also increase the risk of autism in the child. 35 However, results from the stratified analyses conducted in this study, including only children born at term with a normal birth weight and an Apgar score of Ͼ6, were similar to the general results, suggesting that the association between maternal history of AD and autism can not be entirely explained by prenatal or perinatal factors, such as low birth weight, low gestational age, and low Apgar score. In an evaluation of Ͼ500 medical charts of children registered with infantile autism in the DPCR, 94% of the children met the criteria for that diagnosis. The completeness of ASDs diagnosis in the Danish register is assumed to be good; the prevalence of ASDs for 9-year-old children is reported to be 5.1 per 1000, 42 an estimate similar to the American prevalence of 4.2 per 1000 for 8-year-old children living in metropolitan Atlanta, Georgia. 43 The completeness of AD diagnoses is unknown;
however, diagnostic accuracy is informed by a small validation of 2 ADs. We reviewed medical charts on 40 women registered in the DNHR as having RA and 40 women registered in the DNHR as having T1D. Half of the women were diagnosed at a university hospital, and the other half were diagnosed at a regional hospital. Seventyfive percent of the women registered with RA met the operational criteria for RA according to the 1987 Criteria for the Classification of Acute Arthritis of RA from the American College of Rheumatology. 44 Ninety-five percent of the women registered with T1D met the operational criteria for T1D from the American Diabetes Association. 45 
CONCLUSIONS
The results from this study suggest a complex form of association between family history of certain ADs and ASDs/ infantile autism. Findings from previous studies concerning the association between RA and ASDs and T1D and infantile autism are confirmed. Furthermore, this study suggests a probable genetic susceptibility in the case of T1D and a potential prenatal antibody exposure or altered fetal environment in the case of RA. Moreover, a new finding concerning maternal celiac disease and ASDs was presented in this study. More detailed research on the possible common genetic background of ASDs and these specific ADs is suggested. Also, the effect of AD activity during pregnancy on the fetal environment and the potential transfer of maternal antibodies to the fetus are relevant and should be investigated further.
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